Tirzepatide for Weight Loss: What It Is and Who Its For Tirzepatide was approved by the FDA in 2022 for type 2 diabetes, and in 2023 for weight control for people with obesity or overweight and at least one weight-related condition (like high blood pressure or cholesterol)
Long-Term Weight Loss with GLP-1 Agonists: What to Expect GLP-1 agonists are medications that help with weight loss and improve metabolic health, especially for women with PCOS
But Reuters noted that the process has faced criticism since some drugs cleared under this pathway have later been proven ineffective.
The researchers who conducted the new review utilized data from hundreds of clinical studies, preclinical studies, controlled trials, and meta-analyses to learn more about how GLP-1 medications impact the brain
A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
Rx are up to a medical providers discretion and not available in all states
